TipRanks
Shinpoong Pharmaceutical Co., Ltd. (KR:019170)
:019170
South Korea Market
019170
Shinpoong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Shinpoong Pharmaceutical Co., Ltd. (019170) Ratios

― Followers

Shinpoong Pharmaceutical Co., Ltd. Ratios

KR:019170's free cash flow for Q2 2026 was ₩0.42. For the 2026 fiscal year, KR:019170's free cash flow was decreased by ₩ and operating cash flow was ₩-0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.86 3.09 2.50 2.60 7.23
Quick Ratio
 2.02 2.22 1.77 1.90 5.51
Cash Ratio
 0.65 0.71 0.55 0.57 1.53
Solvency Ratio
 0.12 0.25 -0.04 -0.57 -0.73
Operating Cash Flow Ratio
 0.24 0.26 -0.20 -0.33 -0.97
Short-Term Operating Cash Flow Coverage
 0.42 0.40 -0.31 -0.55 0.00
Net Current Asset Value
₩ 123.66B₩ 125.00B₩ 105.32B₩ 119.63B₩ 165.76B
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.16 0.16 0.13 <0.01
Debt-to-Equity Ratio
 0.19 0.21 0.21 0.17 <0.01
Debt-to-Capital Ratio
 0.16 0.17 0.18 0.15 <0.01
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.02 0.00 0.00
Financial Leverage Ratio
 1.32 1.31 1.33 1.30 1.10
Debt Service Coverage Ratio
 0.31 0.55 -0.02 -0.93 -365.41
Interest Coverage Ratio
 0.85 5.30 -7.77 -27.58 -553.86
Debt to Market Cap
 0.11 0.07 0.10 0.06 0.00
Interest Debt Per Share
 1.05K 1.06K 1.08K 934.43 38.81
Net Debt to EBITDA
 0.36 0.33 -464.63 -0.06 1.81
Profitability Margins
Gross Profit Margin
42.36%43.62%37.00%40.09%37.26%
EBIT Margin
1.36%6.07%-5.42%-25.83%-16.59%
EBITDA Margin
6.09%10.93%-0.01%-19.88%-10.47%
Operating Profit Margin
1.07%6.07%-9.25%-23.67%-16.25%
Pretax Profit Margin
<0.01%3.60%-6.61%-26.69%-16.62%
Net Profit Margin
-0.34%3.76%-6.96%-28.63%-16.87%
Continuous Operations Profit Margin
-0.31%3.57%-6.95%-28.60%-16.87%
Net Income Per EBT
-14421.03%104.42%105.23%107.27%101.52%
EBT Per EBIT
0.22%59.29%71.48%112.76%102.24%
Return on Assets (ROA)
-0.22%2.50%-4.50%-16.37%-9.77%
Return on Equity (ROE)
-0.30%3.27%-5.99%-21.26%-10.71%
Return on Capital Employed (ROCE)
0.88%4.99%-7.68%-17.32%-10.17%
Return on Invested Capital (ROIC)
-101.30%4.29%-6.48%-14.83%-10.13%
Return on Tangible Assets
-0.23%2.54%-4.56%-16.65%-9.96%
Earnings Yield
-0.16%1.14%-2.80%-8.13%-3.36%
Efficiency Ratios
Receivables Turnover
 3.23 3.19 3.05 2.44 2.31
Payables Turnover
 15.14 18.64 13.93 13.42 11.49
Inventory Turnover
 2.22 2.26 2.52 2.22 2.80
Fixed Asset Turnover
 2.25 2.16 1.92 1.69 1.84
Asset Turnover
 0.65 0.67 0.65 0.57 0.58
Working Capital Turnover Ratio
 1.70 1.85 1.87 1.37 1.14
Cash Conversion Cycle
 253.26 256.10 238.65 286.54 256.80
Days of Sales Outstanding
 112.89 114.36 119.73 149.67 158.21
Days of Inventory Outstanding
 164.47 161.32 145.12 164.08 130.35
Days of Payables Outstanding
 24.11 19.58 26.20 27.21 31.77
Operating Cycle
 277.37 275.67 264.85 313.75 288.56
Cash Flow Ratios
Operating Cash Flow Per Share
 327.17 312.65 -284.75 -485.03 -515.85
Free Cash Flow Per Share
 252.77 249.64 -399.15 -778.43 -637.36
CapEx Per Share
 74.39 63.01 114.40 293.40 121.51
Free Cash Flow to Operating Cash Flow
 0.77 0.80 1.40 1.60 1.24
Dividend Paid and CapEx Coverage Ratio
 4.40 4.96 -2.49 -1.65 -4.25
Capital Expenditure Coverage Ratio
 4.40 4.96 -2.49 -1.65 -4.25
Operating Cash Flow Coverage Ratio
 0.33 0.31 -0.28 -0.54 -13.71
Operating Cash Flow to Sales Ratio
 0.07 0.07 -0.07 -0.12 -0.13
Free Cash Flow Yield
2.84%1.78%-3.87%-5.65%-3.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -968.59 81.63 -34.35 -12.31 -29.76
Price-to-Sales (P/S) Ratio
 2.00 3.30 2.48 3.52 5.02
Price-to-Book (P/B) Ratio
 1.79 2.87 2.14 2.62 3.19
Price-to-Free Cash Flow (P/FCF) Ratio
 35.24 56.24 -25.83 -17.69 -32.16
Price-to-Operating Cash Flow Ratio
 28.27 44.91 -36.21 -28.39 -39.74
Price-to-Earnings Growth (PEG) Ratio
 7.15 -0.52 0.47 -0.20 -0.14
Price-to-Fair Value
 1.79 2.87 2.14 2.62 3.19
Enterprise Value Multiple
 33.19 30.54 -20.68K -17.78 -46.13
Enterprise Value
 483.49B 783.22B 561.33B 707.78B 1.01T
EV to EBITDA
 33.19 30.54 -20.68K -17.78 -46.13
EV to Sales
 2.02 3.34 2.54 3.53 4.83
EV to Free Cash Flow
 35.62 56.85 -26.42 -17.75 -30.95
EV to Operating Cash Flow
 27.52 45.39 -37.04 -28.48 -38.24
Tangible Book Value Per Share
 5.08K 4.81K 4.76K 5.17K 6.32K
Shareholders’ Equity Per Share
 5.16K 4.89K 4.83K 5.26K 6.43K
Tax and Other Ratios
Effective Tax Rate
 133.05 <0.01 -0.05 -0.07 -0.02
Revenue Per Share
 4.45K 4.25K 4.15K 3.91K 4.08K
Net Income Per Share
 -15.18 159.92 -289.11 -1.12K -688.79
Tax Burden
 -144.21 1.04 1.05 1.07 1.02
Interest Burden
 <0.01 0.59 1.22 1.03 1.00
Research & Development to Revenue
 0.06 0.05 0.08 0.28 0.15
SG&A to Revenue
 0.21 0.12 0.15 0.18 0.17
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -22.51 1.96 0.99 0.43 0.75
Currency in KRW